Oral janus kinase inhibitors for induction of remission in ulcerative colitis

Sachit Anand, Sushil K. Garg, James P. Campbell, Siddharth Singh, Vaibhav Wadhwa, Isra M. Hussein, Atul Kumar, Vineet Ahuja

Research output: Contribution to journalArticlepeer-review

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: The primary objective is to evaluate the efficacy and safety of oral JAK inhibitors for induction of remission in patients with active UC.

Original languageEnglish (US)
Article numberCD012420
JournalCochrane Database of Systematic Reviews
Volume2016
Issue number11
DOIs
StatePublished - Nov 1 2016

Bibliographical note

Publisher Copyright:
© 2016 The Cochrane Collaboration.

Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.

Fingerprint Dive into the research topics of 'Oral janus kinase inhibitors for induction of remission in ulcerative colitis'. Together they form a unique fingerprint.

Cite this